We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
4D Molecular Therapeutics Inc | NASDAQ:FDMT | NASDAQ | Common Stock |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
24.80 | 28.21 | 26.54 | 24.93 | 25.31 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 20.72M | -100.84M | -2.0257 | -13.03 | 1.31B |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
21:02:02 | priorref | 47,000 | 26.38 | USD |
Date | Time | Source | Headline |
---|---|---|---|
21/12/2023 | 17:31 | DJN | 4D Molecular Shares Rise on FDA Designation for Wet AMD Drug |
4D Molecular Therapeutics (FDMT) Share Charts1 Year 4D Molecular Therapeutics Chart |
|
1 Month 4D Molecular Therapeutics Chart |
Intraday 4D Molecular Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions